Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-04 5:35 pm Unchanged | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.3% | 0 (Unchanged) | View |
2024-02-14 07:23 am Purchase | 13G | INNOVIVA INC INVA | PUTNAM INVESTMENTS LLC | 6,270,413 9.8% | 941,306 (+17.66%) | View |
2024-02-13 5:06 pm Sale | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 6,712,443 10.47% | -359,769 (-5.09%) | View |
2024-02-13 10:26 am Sale | 13G | INNOVIVA INC INVA | RENAISSANCE TECHNOLOGIES LLC | 4,144,447 6.47% | -85,160 (-2.01%) | View |
2024-02-09 09:59 am Purchase | 13G | INNOVIVA INC INVA | DIMENSIONAL FUND ADVISORS LP | 4,516,999 7% | 4,516,999 (New Position) | View |
2024-01-22 2:03 pm Sale | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 10,349,116 16.1% | -262,723 (-2.48%) | View |
2023-07-11 08:27 am Unchanged | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.3% | 0 (Unchanged) | View |
2023-05-15 5:05 pm Purchase | 13D | INNOVIVA INC INVA | Sarissa Capital Management LP | 6,904,000 10.54% | 490,000 (+7.64%) | View |
2023-02-14 1:05 pm Purchase | 13G | INNOVIVA INC INVA | PUTNAM INVESTMENTS LLC | 5,329,107 7.6% | 5,329,107 (New Position) | View |
2023-02-13 10:27 am Sale | 13G | INNOVIVA INC INVA | RENAISSANCE TECHNOLOGIES LLC | 4,229,607 6.06% | -1,065,526 (-20.12%) | View |
2023-02-10 2:11 pm Unchanged | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 10,611,839 15.2% | 0 (Unchanged) | View |
2023-02-09 11:22 am Purchase | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 7,072,212 10.13% | 101,262 (+1.45%) | View |
2023-02-01 7:39 pm Purchase | 13G | INNOVIVA INC INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,106,136 5.88% | 422,651 (+11.47%) | View |
2023-01-26 08:52 am Purchase | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 10,611,839 10.6% | 4,940,739 (+87.12%) | View |
2023-01-20 5:17 pm Sale | 13G | INNOVIVA INC INVA | BlackRock Inc. BLK | 5,671,100 10.6% | -3,337,658 (-37.05%) | View |
2023-01-10 5:12 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.3% | 19,736,843 (+44.41%) | View |
2022-07-11 5:27 pm Sale | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 100 100% | -57,345,694 (-100.00%) | View |
2022-07-11 1:13 pm Purchase | 13G | INNOVIVA INC INVA | VANGUARD GROUP INC | 6,970,950 10% | 170,755 (+2.51%) | View |
2022-05-23 8:55 pm Unchanged | 13D | ENTASIS THERAPEUTICS HLDGS INC ETTX | Innoviva Inc. INVA | 57,345,794 74.93% | 0 (Unchanged) | View |
2022-04-01 4:50 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 44,441,416 80.1% | 8,077,812 (+22.21%) | View |